PDE5A and colorectal cancer: While the association between PDE5 inhibitors and colorectal cancer risk is controversial [408, 409], one study indicates that the use of PDE5 inhibitor after surgical resection may be related to a reduced risk of colorectal cancer-specific mortality [410].